Recombinant production of antimicrobial proteins in bacterial expression systems: Escherichia coli vs. lactic acid bacteria
Sergi Travé-Asensio, Oriol Gómez, Jose Vicente Carratalá, Carla Robles, Francesc Fàbregas, Adrià López-Cano, Xavier Rodríguez Rodríguez, Imma Ratera, Anna Arís, Elena Garcia-Fruitós · 2025
Read Recombinant production of antimicrobial proteins in bacterial expression systems: Escherichia coli vs. lactic acid bacteria by Sergi Travé-Asensio, Oriol Gómez, Jose Vicente Carratalá, Carla Robles, Francesc Fàbregas, Adrià López-Cano, Xavier Rodríguez Rodríguez, Imma Ratera, Anna Arís, Elena Garcia-Fruitós (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751592.txt.
Description
Ten authors compare two bacterial factories for making antimicrobial proteins in this 2025 study. New antimicrobials are a global priority as resistance grows, and proteins from the immune system or from virus enzymes that eat bacteria are leading candidates, but they must be produced somehow.
Short peptides can be made chemically, yet that route has limits, so factories inside living bacteria are used. The workhorse is Escherichia coli, while lactic acid bacteria offer a food safe alternative. No study had compared the two head to head for these proteins. The authors run that comparison, judging both yield and killing activity, to guide future production choices.
Catalog record
| CREATOR | Sergi Travé-Asensio, Oriol Gómez, Jose Vicente Carratalá, Carla Robles, Francesc Fàbregas, Adrià López-Cano, Xavier Rodríguez Rodríguez, Imma Ratera, Anna Arís, Elena Garcia-Fruitós |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |